STOCK TITAN

Nakamoto Inc. Form 4 Filings

NAKA NASDAQ

Every Form 4 that Nakamoto Inc. (NAKA) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow NAKA and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full NAKA filings page.

Rhea-AI Summary

Nakamoto Inc. (symbol: NAKA) is the issuer of record for a Form 4 filing submitted to the SEC.

Rhea-AI Summary

Nakamoto Inc. (symbol: NAKA) is the issuer of record for a Form 4 filing submitted to the SEC.

Rhea-AI Summary

Nakamoto Inc. (symbol: NAKA) is the issuer of record for a Form 4 filing submitted to the SEC.

Rhea-AI Summary

Nakamoto Inc. (symbol: NAKA) is the issuer of record for a Form 4 filing submitted to the SEC.

Rhea-AI Summary

Nakamoto Inc. (symbol: NAKA) is the issuer of record for a Form 4 filing submitted to the SEC.

Rhea-AI Summary

Nakamoto Inc. (symbol: NAKA) is the issuer of record for a Form 4 filing submitted to the SEC.

Rhea-AI Summary

Nakamoto Inc. (symbol: NAKA) is the issuer of record for a Form 4 filing submitted to the SEC.

Rhea-AI Summary

Nakamoto Inc. (NAKA) reported equity transactions by director and Chief Investment Officer Evans Tyler Matthew. He received a grant of 250,000 stock options with a $7.06 exercise price, bringing his option holdings to 885,544. He was also granted 56,657 RSUs with a two-year vesting schedule.

In connection with merger agreements, 230 common shares were forfeited and cancelled for no consideration and 3 common shares were issued. All reported share amounts reflect a 1-for-40 reverse stock split of Nakamoto Inc. common stock.

Rhea-AI Summary

Nakamoto Inc. (symbol: NAKA) is the issuer of record for a Form 4 filing submitted to the SEC.

Rhea-AI Summary

Nakamoto Inc. (NAKA) reported insider equity activity by Chief Executive Officer and director Bailey David F, who is also a ten percent owner. On August 21, 2026, he received a grant of 62,500 stock options with an exercise price of $7.06 per share, expiring on August 21, 2036. According to the vesting schedule, this non-qualified option vests over four years from August 14, 2025, with a 12‑month cliff; 15,625 shares were vested and became exercisable on the grant date. He also received 70,821 RSUs that time‑vest over two years from August 14, 2026, with no vesting in the first 12 months, then 25% at the cliff and the remaining 75% in equal quarterly installments over the next year. In connection with merger agreements, 3,744 shares of common stock were forfeited and cancelled for no consideration, while 3 shares were issued to him. Additionally, 32,133.836 shares of common stock are reported as held indirectly by his spouse.

Rhea-AI Summary

Nakamoto Inc. (NAKA) reported open-market purchases of its common stock by Chief Executive Officer and director Bailey David F, who is also a ten percent owner. On 2026-08-20, he directly purchased 4,852 shares at a weighted average price of $6.2675 per share, bringing his direct holdings to 3,185,246 shares. On 2026-08-19, entities associated with him purchased 32,133.836 shares at a weighted average price of $5.5885 per share, held indirectly by his spouse; he disclaims beneficial ownership of those spouse-held shares except to the extent of his pecuniary interest.

Rhea-AI Summary

Nakamoto Inc. (NAKA) reported that Bailey David F, its Chief Executive Officer, director, and ten percent owner, purchased a total of 4,918 shares of common stock on August 18, 2026. The purchases were reported as non-derivative, open market or private transactions at per-share prices between $5.0828 and $5.1499, all held as direct ownership.

Rhea-AI Summary

Nakamoto Inc. director and Chief Executive Officer Bailey David F reported open-market purchases of a total of 55,115 shares of Common Stock of Nakamoto Inc. at prices between $5.59 and $5.79 per share. Following these transactions, he directly owns 3,127,476 shares.

Rhea-AI Summary

Nakamoto Inc. director and CEO Bailey David F reported open-market purchases of a total of 136,333 shares of common stock. The purchases occurred on May 26–27, 2026 at prices between $4.68 and $5.58 per share. Following these transactions, Bailey directly holds 3,120,361 shares of Nakamoto Inc. common stock. A 1-for-40 reverse stock split of the common stock became effective on May 22, 2026, and the reported share amounts reflect this adjustment.

Rhea-AI Summary

Evans Tyler Matthew reported acquisition or exercise transactions in this Form 4 filing.

Nakamoto Inc. reported that Chief Investment Officer Evans Tyler Matthew received a grant of 600,000 shares of Common Stock on March 12, 2026. The filing describes this as a fully vested stock award issued under the 2025 Equity Incentive Plan in partial satisfaction of his 2025 bonus payment. Following this award, he directly holds 20,852,678 shares, reflecting compensation rather than an open-market purchase or sale.

Rhea-AI Summary

Nakamoto Inc. Chief Investment Officer Evans Tyler Matthew reported multiple equity awards in an amended insider filing. On February 20, 2026, he received 17,841,993 shares of Common Stock as a grant/award, consisting of 5,925,156 shares under a BTC Merger Agreement and 11,916,837 shares under a UTXO Management GP merger agreement. He also was granted several fully vested stock options, each exercisable on a one-for-one basis for Common Stock at a $0.07 exercise price, with expiration dates in 2028 and 2029, which were assumed pursuant to the BTC Merger Agreement. Following these transactions, his direct Common Stock holdings were 20,252,678 shares. The amended Form 4 is stated to be filed solely to correct a scrivener's error in the previously disclosed total beneficial ownership.

Rhea-AI Summary

Nakamoto Inc. Chief Investment Officer Evans Tyler Matthew reported multiple equity awards. On February 20, 2026, he acquired stock options labelled as grants or awards, including one for 12,491,284 stock options with a per-share exercise relationship of one option for one share of common stock.

On the same date, he also acquired 17,841,993 shares of common stock at a stated price of $0.00 per share, described as received under two separate merger agreements involving BTC Inc. and UTXO Management GP, LLC. Certain fully vested options were assumed by Nakamoto Inc. pursuant to one of these merger agreements.

Rhea-AI Summary

Nakamoto Inc. reported that Chief Executive Officer and 10% owner Bailey David F acquired 108,200,628 shares of Common Stock on February 20, 2026 as a grant or award transaction at a reported price of $0.0000 per share, leaving him with 119,361,200 shares held directly.

According to the footnote, these shares were received in connection with two merger agreements dated February 16, 2026, involving BTC Inc. and UTXO Management GP, LLC, through which Bailey received shares of Nakamoto Inc. in exchange for interests tied to those entities.

Rhea-AI Summary

Nakamoto Inc. reported that Chief Commercial Officer Creighton Andrew John acquired 1,685,500 stock options on February 20, 2026 through a grant or award. According to the footnote, these options are fully vested and exercisable on a one-for-one basis for Nakamoto Inc. common stock. The options were assumed by Nakamoto Inc. under an Agreement and Plan of Merger dated February 16, 2026, and following this grant he holds 1,685,500 options directly.

Rhea-AI Summary

Jared Barrera, Chief Financial Officer of Kindly MD, Inc. (NAKA), reported a restricted stock award that fully vested on 09/22/2025, resulting in an acquisition of 6,400 shares at no cash price and increasing his beneficial ownership to 22,242 shares. The Form 4, filed by attorney-in-fact on 09/24/2025, shows the transaction was an internal equity award rather than an open-market purchase or sale. The filing includes a standard Exhibit 24 power of attorney signature and does not disclose any cash consideration, option exercises, or derivative transactions.

Rhea-AI Summary

Kindly MD, Inc. (NAKA) insider reported multiple grants to Chief Medical Officer Timothy Pickett on 09/22/2025. The Form 4 shows four non‑derivative transactions reporting the receipt of 37,593 restricted stock units that vest over four years with a 12‑month cliff, plus three fully vested restricted stock awards of 26,129, 10,146, and 18,378 shares, bringing reported beneficial ownership to 191,271 shares after the transactions. All grants were reported with a $0 price, indicating they are equity awards rather than market purchases. The filing is signed by an attorney‑in‑fact on behalf of the reporting person.

Rhea-AI Summary

Eric Stanton Weiss, a director of Kindly MD, Inc. (NAKA), was granted 112,781 restricted stock units (RSUs) reported on a Form 4 with a transaction date of 09/22/2025. The RSUs were recorded at a price of $0 and are shown as directly beneficially owned following the grant. The RSUs vest on August 15, 2026 and are subject to Mr. Weiss’s continued service on the company’s board through that Vesting Date. The Form 4 was signed on behalf of the reporting person by an attorney-in-fact, Kyle Simon, on 09/24/2025.

Rhea-AI Summary

Kindly MD, Inc. (NAKA) director Gregory Elias Xethalis was reported as the sole reporting person on a Form 4 disclosing an award of 112,781 restricted stock units (RSUs) on 09/22/2025. The RSUs are non‑cash, granted at $0 price and are scheduled to vest on August 15, 2026, subject to his continued service on the board through the vesting date. After the reported transaction the filing shows 112,781 shares beneficially owned by the reporting person. The Form is signed by an attorney‑in‑fact on behalf of the reporting person on 09/24/2025.

Rhea-AI Summary

Amanda Fabiano, Chief Operating Officer of Kindly MD, Inc. (NAKA), reported two grants of restricted stock units on 09/22/2025 that increase her direct beneficial ownership to 4,135,337 shares. One grant covers 751,879 RSUs and the second covers 3,383,458 RSUs; both show a transaction price of $0 and are time-vesting over three years with a 12-month cliff beginning August 15, 2025. After the cliff, 25% vests immediately and the remaining 75% vests in equal quarterly installments over the following 24 months, subject to continued service. The larger grant is further contingent on a performance condition: no shares will vest under that grant unless Fabiano causes Second Gate Advisory, LLC (an entity she owns and controls) to assign or transfer certain business arrangements to the issuer. The Form 4 was signed by an attorney-in-fact on 09/24/2025.

Rhea-AI Summary

Kindly MD, Inc. (NAKA) reports a grant of 751,879 restricted stock units (RSUs) to reporting person David F. Bailey in a transaction dated 09/22/2025. The RSUs vest over four years with a 12-month cliff measured from August 15, 2025: 25% vests at the end of the cliff and the remaining 75% vests in equal quarterly installments over the following 36 months, subject to continued service. After this grant the reporting person beneficially owns 11,912,451 shares. The RSUs have no purchase price reported and are time-based equity compensation intended to align executive incentives with shareholder outcomes.

Rhea-AI Summary

Kindly MD, Inc. (NAKA) insider report: Chief Commercial Officer Andrew Creighton was granted 601,503 restricted stock units (RSUs) that will time-vest over four years. There is a 12-month cliff from August 15, 2025, after which 25% vests at cliff completion and the remaining 75% vests in equal quarterly installments over the following 36 months, contingent on continued service. After the grant, Mr. Creighton beneficially owns 3,726,474 shares of common stock. The RSUs were granted at no cash price to the reporting person and are subject to the issuer’s standard vesting and service conditions.

Rhea-AI Summary

Tyler Matthew Evans, Chief Investment Officer of Kindly MD, Inc. (NAKA), was granted 601,503 restricted stock units (RSUs) on 09/22/2025 at a reported price of $0, bringing his total beneficial ownership to 3,012,188 shares. The RSUs vest over four years with a 12-month cliff beginning August 15, 2025, after which 25% vest at the cliff and the remaining 75% vest in equal quarterly installments over the following 36 months. Vesting is contingent on the reporting person’s continued service through each vesting date. The Form 4 was signed by an attorney-in-fact on 09/24/2025.

Rhea-AI Summary

Mark W. Yusko, a director of Kindly MD, Inc. (NAKA), reported an acquisition of 112,781 restricted stock units (RSUs) on 09/22/2025. The filing shows these RSUs were granted at a price of $0 and that the reporting person will beneficially own 2,212,781 shares following the grant. The RSUs vest on August 15, 2026 and are subject to the reporting person ontinuing service on the company oard through that vesting date. The Form 4 was signed and submitted by an attorney-in-fact on behalf of the reporting person.

Rhea-AI Summary

Perianne Boring McNulty, a director of Kindly MD, Inc. (NAKA), reported acquiring 112,781 restricted stock units on 09/22/2025. The RSUs were granted at a $0 price and are scheduled to vest on August 15, 2026, subject to her continued service on the company's board through the vesting date. After this transaction the reporting person beneficially owns 112,781 shares in a direct ownership form. The Form 4 was signed by an attorney-in-fact on 09/24/2025.

Rhea-AI Summary

Kindly MD, Inc. (NAKA) director Charles Phillip Blackburn was granted 112,781 restricted stock units (RSUs) on 09/22/2025, recorded on a Form 4 filed 09/24/2025. The RSUs carry a $0 purchase price and are reported as directly beneficially owned following the grant.

The RSUs are subject to time-based vesting and will vest on August 15, 2026 provided Blackburn continues to serve on the company’s board through that Vesting Date. After the reported transaction, Blackburn is shown as beneficial owner of 112,781 shares tied to these RSUs.